Ads

You May Also Like

ADMA Biologics Reports Second Quarter 2018 Financial Results

Key Regulatory & Manufacturing Milestones AchievedRAMSEY, N.J. and BOCA RATON, Fla., Aug. 10, 2018 ...

G1 Therapeutics Provides Second Quarter 2018 Corporate and Financial Update

Presenting additional data from randomized Phase 2 trilaciclib/chemotherapy trial in first-line small cell lung ...